Cargando…
Electrocardiographic features of immune checkpoint inhibitor associated myocarditis
BACKGROUND: Myocarditis is a highly morbid complication of immune checkpoint inhibitor (ICI) use that remains inadequately characterized. The QRS duration and the QTc interval are standardized electrocardiographic measures that are prolonged in other cardiac conditions; however, there are no data on...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7929895/ https://www.ncbi.nlm.nih.gov/pubmed/33653803 http://dx.doi.org/10.1136/jitc-2020-002007 |
_version_ | 1783659999475531776 |
---|---|
author | Zlotoff, Daniel A Hassan, Malek Z O Zafar, Amna Alvi, Raza M Awadalla, Magid Mahmood, Syed S Zhang, Lili Chen, Carol L Ederhy, Stephane Barac, Ana Banerji, Dahlia Jones-O'Connor, Maeve Murphy, Sean P Armanious, Merna Forrestal, Brian J Kirchberger, Michael C Coelho-Filho, Otavio R Rizvi, Muhammad A Sahni, Gagan Mandawat, Anant Tocchetti, Carlo G Hartmann, Sarah Gilman, Hannah K Zatarain-Nicolás, Eduardo Mahmoudi, Michael Gupta, Dipti Sullivan, Ryan Ganatra, Sarju Yang, Eric H Heinzerling, Lucie M Thuny, Franck Zubiri, Leyre Reynolds, Kerry L Cohen, Justine V Lyon, Alexander R Groarke, John Thavendiranathan, Paaladinesh Nohria, Anju Fradley, Michael G Neilan, Tomas G |
author_facet | Zlotoff, Daniel A Hassan, Malek Z O Zafar, Amna Alvi, Raza M Awadalla, Magid Mahmood, Syed S Zhang, Lili Chen, Carol L Ederhy, Stephane Barac, Ana Banerji, Dahlia Jones-O'Connor, Maeve Murphy, Sean P Armanious, Merna Forrestal, Brian J Kirchberger, Michael C Coelho-Filho, Otavio R Rizvi, Muhammad A Sahni, Gagan Mandawat, Anant Tocchetti, Carlo G Hartmann, Sarah Gilman, Hannah K Zatarain-Nicolás, Eduardo Mahmoudi, Michael Gupta, Dipti Sullivan, Ryan Ganatra, Sarju Yang, Eric H Heinzerling, Lucie M Thuny, Franck Zubiri, Leyre Reynolds, Kerry L Cohen, Justine V Lyon, Alexander R Groarke, John Thavendiranathan, Paaladinesh Nohria, Anju Fradley, Michael G Neilan, Tomas G |
author_sort | Zlotoff, Daniel A |
collection | PubMed |
description | BACKGROUND: Myocarditis is a highly morbid complication of immune checkpoint inhibitor (ICI) use that remains inadequately characterized. The QRS duration and the QTc interval are standardized electrocardiographic measures that are prolonged in other cardiac conditions; however, there are no data on their utility in ICI myocarditis. METHODS: From an international registry, ECG parameters were compared between 140 myocarditis cases and 179 controls across multiple time points (pre-ICI, on ICI prior to myocarditis, and at the time of myocarditis). The association between ECG values and major adverse cardiac events (MACE) was also tested. RESULTS: Both the QRS duration and QTc interval were similar between cases and controls prior to myocarditis. When compared with controls on an ICI (93±19 ms) or to baseline prior to myocarditis (97±19 ms), the QRS duration prolonged with myocarditis (110±22 ms, p<0.001 and p=0.009, respectively). In contrast, the QTc interval at the time of myocarditis (435±39 ms) was not increased compared with pre-myocarditis baseline (422±27 ms, p=0.42). A prolonged QRS duration conferred an increased risk of subsequent MACE (HR 3.28, 95% CI 1.98 to 5.62, p<0.001). After adjustment, each 10 ms increase in the QRS duration conferred a 1.3-fold increase in the odds of MACE (95% CI 1.07 to 1.61, p=0.011). Conversely, there was no association between the QTc interval and MACE among men (HR 1.33, 95% CI 0.70 to 2.53, p=0.38) or women (HR 1.48, 95% CI 0.61 to 3.58, p=0.39). CONCLUSIONS: The QRS duration is increased in ICI myocarditis and is associated with increased MACE risk. Use of this widely available ECG parameter may aid in ICI myocarditis diagnosis and risk-stratification. |
format | Online Article Text |
id | pubmed-7929895 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-79298952021-03-19 Electrocardiographic features of immune checkpoint inhibitor associated myocarditis Zlotoff, Daniel A Hassan, Malek Z O Zafar, Amna Alvi, Raza M Awadalla, Magid Mahmood, Syed S Zhang, Lili Chen, Carol L Ederhy, Stephane Barac, Ana Banerji, Dahlia Jones-O'Connor, Maeve Murphy, Sean P Armanious, Merna Forrestal, Brian J Kirchberger, Michael C Coelho-Filho, Otavio R Rizvi, Muhammad A Sahni, Gagan Mandawat, Anant Tocchetti, Carlo G Hartmann, Sarah Gilman, Hannah K Zatarain-Nicolás, Eduardo Mahmoudi, Michael Gupta, Dipti Sullivan, Ryan Ganatra, Sarju Yang, Eric H Heinzerling, Lucie M Thuny, Franck Zubiri, Leyre Reynolds, Kerry L Cohen, Justine V Lyon, Alexander R Groarke, John Thavendiranathan, Paaladinesh Nohria, Anju Fradley, Michael G Neilan, Tomas G J Immunother Cancer Clinical/Translational Cancer Immunotherapy BACKGROUND: Myocarditis is a highly morbid complication of immune checkpoint inhibitor (ICI) use that remains inadequately characterized. The QRS duration and the QTc interval are standardized electrocardiographic measures that are prolonged in other cardiac conditions; however, there are no data on their utility in ICI myocarditis. METHODS: From an international registry, ECG parameters were compared between 140 myocarditis cases and 179 controls across multiple time points (pre-ICI, on ICI prior to myocarditis, and at the time of myocarditis). The association between ECG values and major adverse cardiac events (MACE) was also tested. RESULTS: Both the QRS duration and QTc interval were similar between cases and controls prior to myocarditis. When compared with controls on an ICI (93±19 ms) or to baseline prior to myocarditis (97±19 ms), the QRS duration prolonged with myocarditis (110±22 ms, p<0.001 and p=0.009, respectively). In contrast, the QTc interval at the time of myocarditis (435±39 ms) was not increased compared with pre-myocarditis baseline (422±27 ms, p=0.42). A prolonged QRS duration conferred an increased risk of subsequent MACE (HR 3.28, 95% CI 1.98 to 5.62, p<0.001). After adjustment, each 10 ms increase in the QRS duration conferred a 1.3-fold increase in the odds of MACE (95% CI 1.07 to 1.61, p=0.011). Conversely, there was no association between the QTc interval and MACE among men (HR 1.33, 95% CI 0.70 to 2.53, p=0.38) or women (HR 1.48, 95% CI 0.61 to 3.58, p=0.39). CONCLUSIONS: The QRS duration is increased in ICI myocarditis and is associated with increased MACE risk. Use of this widely available ECG parameter may aid in ICI myocarditis diagnosis and risk-stratification. BMJ Publishing Group 2021-03-02 /pmc/articles/PMC7929895/ /pubmed/33653803 http://dx.doi.org/10.1136/jitc-2020-002007 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/. |
spellingShingle | Clinical/Translational Cancer Immunotherapy Zlotoff, Daniel A Hassan, Malek Z O Zafar, Amna Alvi, Raza M Awadalla, Magid Mahmood, Syed S Zhang, Lili Chen, Carol L Ederhy, Stephane Barac, Ana Banerji, Dahlia Jones-O'Connor, Maeve Murphy, Sean P Armanious, Merna Forrestal, Brian J Kirchberger, Michael C Coelho-Filho, Otavio R Rizvi, Muhammad A Sahni, Gagan Mandawat, Anant Tocchetti, Carlo G Hartmann, Sarah Gilman, Hannah K Zatarain-Nicolás, Eduardo Mahmoudi, Michael Gupta, Dipti Sullivan, Ryan Ganatra, Sarju Yang, Eric H Heinzerling, Lucie M Thuny, Franck Zubiri, Leyre Reynolds, Kerry L Cohen, Justine V Lyon, Alexander R Groarke, John Thavendiranathan, Paaladinesh Nohria, Anju Fradley, Michael G Neilan, Tomas G Electrocardiographic features of immune checkpoint inhibitor associated myocarditis |
title | Electrocardiographic features of immune checkpoint inhibitor associated myocarditis |
title_full | Electrocardiographic features of immune checkpoint inhibitor associated myocarditis |
title_fullStr | Electrocardiographic features of immune checkpoint inhibitor associated myocarditis |
title_full_unstemmed | Electrocardiographic features of immune checkpoint inhibitor associated myocarditis |
title_short | Electrocardiographic features of immune checkpoint inhibitor associated myocarditis |
title_sort | electrocardiographic features of immune checkpoint inhibitor associated myocarditis |
topic | Clinical/Translational Cancer Immunotherapy |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7929895/ https://www.ncbi.nlm.nih.gov/pubmed/33653803 http://dx.doi.org/10.1136/jitc-2020-002007 |
work_keys_str_mv | AT zlotoffdaniela electrocardiographicfeaturesofimmunecheckpointinhibitorassociatedmyocarditis AT hassanmalekzo electrocardiographicfeaturesofimmunecheckpointinhibitorassociatedmyocarditis AT zafaramna electrocardiographicfeaturesofimmunecheckpointinhibitorassociatedmyocarditis AT alvirazam electrocardiographicfeaturesofimmunecheckpointinhibitorassociatedmyocarditis AT awadallamagid electrocardiographicfeaturesofimmunecheckpointinhibitorassociatedmyocarditis AT mahmoodsyeds electrocardiographicfeaturesofimmunecheckpointinhibitorassociatedmyocarditis AT zhanglili electrocardiographicfeaturesofimmunecheckpointinhibitorassociatedmyocarditis AT chencaroll electrocardiographicfeaturesofimmunecheckpointinhibitorassociatedmyocarditis AT ederhystephane electrocardiographicfeaturesofimmunecheckpointinhibitorassociatedmyocarditis AT baracana electrocardiographicfeaturesofimmunecheckpointinhibitorassociatedmyocarditis AT banerjidahlia electrocardiographicfeaturesofimmunecheckpointinhibitorassociatedmyocarditis AT jonesoconnormaeve electrocardiographicfeaturesofimmunecheckpointinhibitorassociatedmyocarditis AT murphyseanp electrocardiographicfeaturesofimmunecheckpointinhibitorassociatedmyocarditis AT armaniousmerna electrocardiographicfeaturesofimmunecheckpointinhibitorassociatedmyocarditis AT forrestalbrianj electrocardiographicfeaturesofimmunecheckpointinhibitorassociatedmyocarditis AT kirchbergermichaelc electrocardiographicfeaturesofimmunecheckpointinhibitorassociatedmyocarditis AT coelhofilhootavior electrocardiographicfeaturesofimmunecheckpointinhibitorassociatedmyocarditis AT rizvimuhammada electrocardiographicfeaturesofimmunecheckpointinhibitorassociatedmyocarditis AT sahnigagan electrocardiographicfeaturesofimmunecheckpointinhibitorassociatedmyocarditis AT mandawatanant electrocardiographicfeaturesofimmunecheckpointinhibitorassociatedmyocarditis AT tocchetticarlog electrocardiographicfeaturesofimmunecheckpointinhibitorassociatedmyocarditis AT hartmannsarah electrocardiographicfeaturesofimmunecheckpointinhibitorassociatedmyocarditis AT gilmanhannahk electrocardiographicfeaturesofimmunecheckpointinhibitorassociatedmyocarditis AT zatarainnicolaseduardo electrocardiographicfeaturesofimmunecheckpointinhibitorassociatedmyocarditis AT mahmoudimichael electrocardiographicfeaturesofimmunecheckpointinhibitorassociatedmyocarditis AT guptadipti electrocardiographicfeaturesofimmunecheckpointinhibitorassociatedmyocarditis AT sullivanryan electrocardiographicfeaturesofimmunecheckpointinhibitorassociatedmyocarditis AT ganatrasarju electrocardiographicfeaturesofimmunecheckpointinhibitorassociatedmyocarditis AT yangerich electrocardiographicfeaturesofimmunecheckpointinhibitorassociatedmyocarditis AT heinzerlingluciem electrocardiographicfeaturesofimmunecheckpointinhibitorassociatedmyocarditis AT thunyfranck electrocardiographicfeaturesofimmunecheckpointinhibitorassociatedmyocarditis AT zubirileyre electrocardiographicfeaturesofimmunecheckpointinhibitorassociatedmyocarditis AT reynoldskerryl electrocardiographicfeaturesofimmunecheckpointinhibitorassociatedmyocarditis AT cohenjustinev electrocardiographicfeaturesofimmunecheckpointinhibitorassociatedmyocarditis AT lyonalexanderr electrocardiographicfeaturesofimmunecheckpointinhibitorassociatedmyocarditis AT groarkejohn electrocardiographicfeaturesofimmunecheckpointinhibitorassociatedmyocarditis AT thavendiranathanpaaladinesh electrocardiographicfeaturesofimmunecheckpointinhibitorassociatedmyocarditis AT nohriaanju electrocardiographicfeaturesofimmunecheckpointinhibitorassociatedmyocarditis AT fradleymichaelg electrocardiographicfeaturesofimmunecheckpointinhibitorassociatedmyocarditis AT neilantomasg electrocardiographicfeaturesofimmunecheckpointinhibitorassociatedmyocarditis |